Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Oncology Revenue	23.93B	20.28B	Log In	Log In	Log In	Upgrade
BioPharmaceuticals: CVRM Revenue	12.86B	12.45B	Log In	Log In	Log In	Upgrade
BioPharmaceuticals: R&I Revenue	8.48B	7.42B	Log In	Log In	Log In	Upgrade
BioPharmaceuticals V&I Revenue	1.20B	1.06B	Log In	Log In	Log In	Upgrade
Rare Disease Revenue	9.03B	8.67B	Log In	Log In	Log In	Upgrade
Other Medicines Revenue	1.00B	1.07B	Log In	Log In	Log In	Upgrade
COVID-19 Revenue	-	-	Log In	Log In	Log In	Upgrade
Collaboration Revenue	1.62B	3.14B	Log In	Log In	Log In	Upgrade
Revenue (Total)	58.13B	54.07B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
UK Revenue	-	4.74B	Log In	Log In	Log In	Upgrade
Rest of Europe Revenue	-	11.70B	Log In	Log In	Log In	Upgrade
The Americas Revenue	-	24.99B	Log In	Log In	Log In	Upgrade
Asia, Africa & Australasia Revenue	-	12.64B	Log In	Log In	Log In	Upgrade
Revenue (Total)	58.13B	54.07B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
UK Operating Profit	-	2.68B	Log In	Log In	Log In	Upgrade
Rest of Europe Operating Profit	-	5.92B	Log In	Log In	Log In	Upgrade
The Americas Operating Profit	-	423.00M	Log In	Log In	Log In	Upgrade
Asia, Africa & Australasia Operating Profit	-	976.00M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	12.80B	10.00B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
UK Assets Acquired	582.00M	Log In	Log In	Log In	Upgrade
Rest of Europe Assets Acquired	2.23B	Log In	Log In	Log In	Upgrade
The Americas Assets Acquired	3.93B	Log In	Log In	Log In	Upgrade
Asia, Africa & Australasia Assets Acquired	1.39B	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.